logo

For the Inventor, By the Inventor

Kagoshima, Japan

Kagoshima University


USPTO Granted Patents = 80

% Expired Patents = 38.8


Forward Citations = 109

Loading Chart...
Loading Chart...

192 inventors (with patents filed for the assignee):

goldMedal Yuji Ito (15 out of 17 patents)

silverMedal Yasuo Suda (6 out of 7 patents)

bronzeMedal Masanori Baba (5 out of 37 patents)

4.  Nobuaki Takahashi (4 out of 84 patents)

5.  Ryosuke Nakano (4 out of 6 patents)

6.  Sayaka Maeda (4 out of 5 patents)

7.  Ikuro Maruyama (4 out of 7 patents)

8.  Seiichi Uchimura (3 out of 6 patents)

9.  Ken-ichiro Kosai (3 out of 4 patents)

10.  Kenji Ohsawa (3 out of 5 patents)

11.  Katsuya Tsuruta (3 out of 5 patents)

12.  Kei Mizuta (3 out of 3 patents)

13.  Kazuhisa Sugimura (3 out of 10 patents)

14.  Takashi Kurihara (3 out of 42 patents)

15.  Akio Arano (3 out of 4 patents)


Core Competencies:
Antibody Development
Vaccine Technology
Drug Delivery Systems
Oncolytic Virus
Antiviral Agents
Peptide Vaccines
Therapeutic Drugs
Biomarkers
Microcapsules
Hollow Particles
Image Processing
Hydrogen Production

80 patents:

1. 12583564 - Seafarer safety device, seafarer safety system, seafarer safety program, vessel activity inference device, report generation assistance system, and vessel activity inference program (2026-03-24),
2. 12503575 - Fine hollow particles comprising melamine-based resin (2025-12-23),
3. 12458643 - Antidepressant/anxiolytic drug in which PAC1 receptor antagonist is used (2025-11-04),
4. 12447446 - Bubble formation device and bubble formation method (2025-10-21),
5. 12400018 - Data distribution system, data distribution device, recording medium, and data distribution method (2025-08-26),
6. 12297268 - Antibody which binds to myelin oligodendrocyte glycoprotein (2025-05-13),
7. 12280099 - Dengue virus vaccine (2025-04-21),
8. RE50282 - Specific modification of antibody with IgG-binding peptide (2025-01-28),
9. 12202858 - Solid-phase carrier including IgG-binding peptide, and IgG separation method (2025-01-21),
10. 12037417 - Site-specific radioisotope-labeled antibody using IgG-binding peptide (2024-07-16),
11. 11965035 - Antibody binding to chondroitin sulfate proteoglycan 5 (2024-04-23),
12. 11896635 - Oncolytic virus (oncolytic immunotherapy) capable of effectively treating even metastatic cancer while ensuring safety, with expression control system providing optimal expression level of mounted immunogenic gene (2024-02-13),
13. 11873337 - Antibody binding to cell adhesion molecule 3 (2024-01-16),
14. 11701440 - Modified antibody and radioactive metal-labelled antibody (2023-07-18),
15. 11643474 - Peptide fusion protein (2023-05-09),
Company Overview
Kagoshima University, located in Japan, is a prominent institution focused on biomedical innovation. The university specializes in various core technology areas, including antibody development, vaccine technology, and drug delivery systems. Its research initiatives extend to oncolytic viruses, antiviral agents, peptide vaccines, therapeutic drugs, and biomarkers, contributing significantly to advancements in healthcare. The institution fosters collaboration and innovation, aiming to address pressing medical challenges through cutting-edge research and development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

80 Patents

#1 in Kagoshima

#1,304 in Japan

#9,454 in the World

Kagoshima, JP
Kagoshima, Japan

Kagoshima University

Forward Citations = 109

192 inventors:

goldMedal Yuji Ito (15 out of 17 patents)

silverMedal Yasuo Suda (6 out of 7 patents)

bronzeMedal Masanori Baba (5 out of 37 patents)

4.  Nobuaki Takahashi (4 out of 84 patents)

5.  Ryosuke Nakano (4 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kagoshima University. Retrieved from https://idiyas.com/company/kagoshima-university

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…